BR112012027282A2 - meio de cultura de células aperfeiçoado - Google Patents

meio de cultura de células aperfeiçoado

Info

Publication number
BR112012027282A2
BR112012027282A2 BR112012027282A BR112012027282A BR112012027282A2 BR 112012027282 A2 BR112012027282 A2 BR 112012027282A2 BR 112012027282 A BR112012027282 A BR 112012027282A BR 112012027282 A BR112012027282 A BR 112012027282A BR 112012027282 A2 BR112012027282 A2 BR 112012027282A2
Authority
BR
Brazil
Prior art keywords
cell culture
culture medium
improved cell
producing polypeptides
shift
Prior art date
Application number
BR112012027282A
Other languages
English (en)
Other versions
BR112012027282B1 (pt
Inventor
Christian Leist
Jörg Schmidt
Petra Meissner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44074260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012027282(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112012027282A2 publication Critical patent/BR112012027282A2/pt
Publication of BR112012027282B1 publication Critical patent/BR112012027282B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

meio de cultura de células aperfeiçoado. a presente invenção refere-se a um meio otimizado para o crescimento de células de mamíferos, bem como a produção de polipeptídeos. o meio de cultura de células é distiguido por uma razão sow de íons de sódio para potássio, e ele refere-se ainda ao método para produzir polipeptídeos usando tais meios de cultura de células. em outro aspecto, o método para produzir polipeptídeos usando pode compreender também um deslocamento de temperatura e/ou um deslocamento de ph para otimizar ainda mais o crescimento e o rendimento do produto.
BR112012027282-9A 2010-04-26 2011-04-25 Meio de cultura de células aperfeiçoado e processo para a produção de um polipeptídeo recombinante BR112012027282B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32783610P 2010-04-26 2010-04-26
US61/327,836 2010-04-26
PCT/EP2011/056508 WO2011134920A1 (en) 2010-04-26 2011-04-25 Improved cell culture medium

Publications (2)

Publication Number Publication Date
BR112012027282A2 true BR112012027282A2 (pt) 2015-09-22
BR112012027282B1 BR112012027282B1 (pt) 2020-09-29

Family

ID=44074260

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012027282-9A BR112012027282B1 (pt) 2010-04-26 2011-04-25 Meio de cultura de células aperfeiçoado e processo para a produção de um polipeptídeo recombinante

Country Status (17)

Country Link
US (2) US9428727B2 (pt)
EP (1) EP2563904B1 (pt)
JP (3) JP6347949B2 (pt)
KR (1) KR101828623B1 (pt)
CN (1) CN102858952B (pt)
AU (1) AU2011246503B2 (pt)
BR (1) BR112012027282B1 (pt)
CA (1) CA2797356C (pt)
DK (1) DK2563904T3 (pt)
ES (1) ES2533074T3 (pt)
IL (1) IL222452B (pt)
MX (1) MX2012012526A (pt)
PL (1) PL2563904T3 (pt)
PT (1) PT2563904E (pt)
RU (1) RU2644651C2 (pt)
SG (1) SG185038A1 (pt)
WO (1) WO2011134920A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
KR20090074040A (ko) 2006-09-13 2009-07-03 아보트 러보러터리즈 세포 배양의 개선
SG10201702922VA (en) 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
US9428727B2 (en) * 2010-04-26 2016-08-30 Novartis Ag Cell culture medium
MX2012012525A (es) 2010-04-26 2012-11-23 Novartis Ag Medio de cultivo mejorado.
MX345885B (es) * 2010-12-07 2017-02-22 Hoffmann La Roche Dispositivo de mezclado de alimentacion y su uso.
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US10493151B2 (en) 2011-10-18 2019-12-03 Coherus Biosciences, Inc. Etanercept formulations stabilized with sodium chloride
JP6113176B2 (ja) 2011-10-18 2017-04-12 コヒラス・バイオサイエンシズ・インコーポレイテッド キシリトールによって安定化されたエタネルセプト製剤
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
EA029193B1 (ru) 2012-07-09 2018-02-28 Кохерус Байосайенсис, Инк. Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
IN2015KN00452A (pt) 2012-09-11 2015-07-17 Coherus Biosciences Inc
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014158231A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. Low acidic species compositions and methods for producing and using the same
JP2016527911A (ja) 2013-08-20 2016-09-15 レック・ファーマシューティカルズ・ディー・ディーＬｅｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｄ．Ｄ． ポリペプチドのα−アミド化および／またはＣ末端アミノ酸開裂を制御するための細胞培養用培地およびプロセス
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
AU2014331776B2 (en) * 2013-10-11 2020-10-22 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
MX362923B (es) * 2014-01-30 2019-02-25 Coherus Biosciences Inc Medios de perfusión.
RU2710726C2 (ru) 2014-04-29 2020-01-10 Новартис Аг Новые клетки позвоночных и способы рекомбинантной экспрессии интересующего полипептида
ES2733298T3 (es) 2014-07-18 2019-11-28 Sandoz Ag Cuantificación de TNFR2:Fc plegado erróneamente
JP6876049B2 (ja) * 2015-12-17 2021-05-26 ライフ テクノロジーズ コーポレーション 細胞培養に使用されるペレットおよびその製造方法
US20190112572A1 (en) * 2016-04-05 2019-04-18 Pfizer Inc. Cell culture process
EP3601586A1 (en) * 2017-03-31 2020-02-05 Boehringer Ingelheim International GmbH Perfusion medium
CN110462054B (zh) * 2017-03-31 2023-11-10 勃林格殷格翰国际公司 灌注培养基
EP4056678A4 (en) * 2019-11-05 2023-12-06 Ajinomoto Co., Inc. METHOD FOR PRODUCING A PROTEIN
WO2022036275A2 (en) * 2020-08-14 2022-02-17 Bristol-Myers Squibb Company Manufacturing process for protein
UY39484A (es) 2020-11-02 2022-06-30 Novartis Ag Inhibidores de interleucina-17

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
DE3871206D1 (de) 1987-03-24 1992-06-25 Grace W R & Co Basisnaehrmedium fuer eine zellkultur.
US6048728A (en) * 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
US5135866A (en) 1989-03-03 1992-08-04 W. R. Grace & Co.-Conn. Very low protein nutrient medium for cell culture
CA2001550A1 (en) 1989-03-03 1990-09-03 Aaron H. Heifetz Very low protein nutrient medium for cell culture
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH0789908B2 (ja) 1991-02-28 1995-10-04 倉敷紡績株式会社 動物細胞培養用無血清培地
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5830761A (en) 1995-06-07 1998-11-03 Genetics Institute, Inc. Medium and methods for culturing mammalian cho cells
EP1482031B1 (en) * 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US7294481B1 (en) 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
EP1757700A3 (en) 1999-04-26 2009-03-11 Genentech, Inc. Cell culture process for glycoproteins
AU4980200A (en) 1999-05-27 2000-12-18 Pharmacia & Upjohn Company Methods and compositions for measuring ion channel conductance
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
AU780653B2 (en) 1999-12-28 2005-04-07 Isotis N.V. Cell culture medium containing growth factors and L-glutamine
WO2002066603A2 (en) 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
US20030087372A1 (en) 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
DK1543106T3 (da) 2002-07-15 2007-08-13 Immunex Corp Fremgangsmåder og medier til kontrol af sialylering af proteiner, der dannes af mammaliaceller
MXPA05006523A (es) 2002-12-23 2005-08-26 Squibb Bristol Myers Co Procesos de cultivo de celulas de mamiferos para la produccion de proteinas.
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
DE10338536A1 (de) 2003-08-19 2005-04-07 Bircher Reglomat Ag Verfahren zum Betreiben eines Radarsensors
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
TWI374935B (en) 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
WO2006113629A1 (en) 2005-04-15 2006-10-26 The Trustees Of Columbia University In The City Of New York Chemically defined culture media for expansion and differentiation of epidermal cells and uses thereof for in vitro growth of hair follicles
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
US20070190057A1 (en) * 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
US9428727B2 (en) * 2010-04-26 2016-08-30 Novartis Ag Cell culture medium

Also Published As

Publication number Publication date
CA2797356A1 (en) 2011-11-03
RU2018101201A3 (pt) 2021-05-27
USRE48864E1 (en) 2021-12-28
CA2797356C (en) 2020-12-29
AU2011246503B2 (en) 2013-09-26
ES2533074T3 (es) 2015-04-07
CN102858952A (zh) 2013-01-02
US20130122543A1 (en) 2013-05-16
IL222452A0 (en) 2012-12-31
JP2013524825A (ja) 2013-06-20
US9428727B2 (en) 2016-08-30
PL2563904T3 (pl) 2015-06-30
IL222452B (en) 2019-03-31
RU2644651C2 (ru) 2018-02-13
JP7034991B2 (ja) 2022-03-14
BR112012027282B1 (pt) 2020-09-29
AU2011246503A1 (en) 2012-11-22
DK2563904T3 (en) 2015-04-07
EP2563904A1 (en) 2013-03-06
MX2012012526A (es) 2012-11-23
PT2563904E (pt) 2015-05-12
JP6603628B2 (ja) 2019-11-06
JP6347949B2 (ja) 2018-06-27
WO2011134920A1 (en) 2011-11-03
KR20130058699A (ko) 2013-06-04
JP2019216728A (ja) 2019-12-26
EP2563904B1 (en) 2015-01-21
SG185038A1 (en) 2012-11-29
RU2018101201A (ru) 2019-02-21
RU2012150346A (ru) 2014-06-10
KR101828623B1 (ko) 2018-02-12
CN102858952B (zh) 2015-10-14
JP2017012180A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
BR112012027282A2 (pt) meio de cultura de células aperfeiçoado
BR112012027430A2 (pt) processo de cultivo de células aprimorado
EP4148121A3 (en) Cell-controlled perfusion in continuous culture
MY156588A (en) Systems using cell culture for production of isoprene
WO2010089151A8 (en) Bioreactor for the cultivation of mammalian cells
BR112012009828B8 (pt) Método para a produção de uma imunoglobulina glicosilada e seu uso
BR112018003214A2 (pt) fabricação de fosfatases alcalinas
MY182355A (en) Hmo synthesis
WO2008153180A1 (ja) 脂肪組織由来細胞から肝小葉様細胞塊を得る方法
MY166973A (en) Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
MX2011008495A (es) Formulaciones de caldo de fermentacion.
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
MX351974B (es) Cultivo de celulas de mamifero.
BR112017021255A2 (pt) microrganismo modificado para a produção otimizada de 2,4-di-hidroxibutirato
WO2010096588A3 (en) Cell culture media containing combinations of proteins
MX2013007650A (es) Metodo de cultivo de celulas animales.
BRPI0813359A2 (pt) Ácidos nucleicos isolados, vetor, células, métodos para produzir um hidrocarboneto, para produzir uma cetona alifática, para produzir um polipeptídeo purificado, para produzir um hidrocarboneto, para produzir biocombustíveis, hidrocarboneto, biocombustível, polipeptídeo isolado, ácido nucleico isolado, organismos geneticamente engenheirados, método para identificar uma enzima útil para a produção de hidrocarbonetos
EA201390444A1 (ru) Производство бутанола из монооксида углерода рекомбинантным микроорганизмом
NO20064379L (no) Anvendelse av et serumfritt cellekulturmedium for produsjonen av IL-18BP i pattedyrceller
WO2008090770A1 (ja) Ｌ－アミノ酸を生産する微生物及びｌ－アミノ酸の製造法
IN2014DN09244A (pt)
MX2009007114A (es) Produccion de enzima en un medio de cultivo que comprende glicerol crudo.
EA201101626A1 (ru) Бактерии с высокоэффективным метаболизмом
WO2012129962A8 (zh) 一种联合制碱大循环工艺
MY163228A (en) Process for Producing 3-Hydroxybutyric Acid or Salt Thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/04/2011, OBSERVADAS AS CONDICOES LEGAIS.